PubMed · 2003 · 212 citations · 19 references
MedicineGeneticsOncologyMolecular OncologyNeoplasiaTransgenic Animal ModelsCancer ProgressionMalignant NeoplasmsOncogene MutationsPancreatic CancerPancreatic DiseasesPancreatic PathologyAcinar Cell CarcinomaDuctal ArchitectureHuman Disease ModelsPancreatic Duct LesionsPancreatic Ductal DysplasiaPreinvasive NeoplasiaTransgenic MiceTransgenic Mouse Cancer Models
Activating mutation of the Kras oncogene is the most frequent and perhaps the earliest genetic alteration associated with pancreatic cancer. To examine the link between mutant Kras and exocrine pancreatic cancer, we generated transgenic mice carrying an elastase-mutant Kras transgene, which targets expression to pancreatic acinar cells. Most elastase-Kras founder mice displayed perinatal pancreatic acinar cell hyperplasia and dysplasia. However, adult mice in two surviving lineages displayed preinvasive pancreatic neoplastic lesions with ductal morphology, thereby providing a unique mouse model in which lesion histotype and initiating genetic alteration overlap with the human disease. Our findings suggest that Kras mutation is associated with development of early stage duct-like lesions in pancreas, but that additional alterations must accompany progression to malignancy.
19
Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2001 · 3.3K citations · Full text
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Concepción Almoguera, Darryl Shibata, Kathleen Forrester et al. · Cell · 1988 · 2.1K citations
Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice
Carol J. Quaife, Carl A. Pinkert, David M. Ornitz et al. · Cell · 1987 · 267 citations